agilon health, inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
agilon health, inc. (AGL) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $227.53 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $227.53M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $181.43M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $126.73M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $306.08M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $227.53M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $181.43M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $126.73M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $306.08M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $408.93M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $500.25M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $470.95M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $574.87M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $675.87M 10-Q · filed 2025-11-04 |
| 2024-03-31 | $688.49M 10-Q · filed 2025-08-04 |
| 2023-12-31 | $661.02M 10-K · filed 2026-02-25 |
| 2023-09-30 | $871.60M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $879.45M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $1.08B 10-Q · filed 2024-08-06 |
| 2022-12-31 | $1.04B 10-K · filed 2026-02-25 |
| 2022-09-30 | $1.09B 10-Q · filed 2023-11-02 |
| 2022-06-30 | $1.10B 10-Q · filed 2023-11-02 |
| 2022-03-31 | $1.11B 10-Q · filed 2023-08-03 |
| 2021-12-31 | $1.09B 10-K · filed 2025-02-25 |
| 2021-09-30 | $1.13B 10-Q · filed 2022-11-03 |
| 2021-06-30 | $1.15B 10-Q · filed 2022-11-03 |
| 2021-03-31 | -$298.24M 10-Q · filed 2022-08-04 |
| 2020-12-31 | -$284.73M 10-K · filed 2024-02-27 |
| 2020-09-30 | -$262.29M 10-Q · filed 2021-10-28 |
| 2020-06-30 | -$248.28M 10-Q · filed 2021-10-28 |
| 2020-03-31 | -$247.51M 10-Q · filed 2021-08-04 |
| 2019-12-31 | -$232.03M 10-K · filed 2023-03-01 |
| 2018-12-31 | $41.60M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |